Funder
National Natural Science Foundation of China
Reference35 articles.
1. Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination;Suryawanshi;Nature,2022
2. Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series;Argenziano;BMJ,2020
3. Impact of severe acute respiratory syndrome coronavirus 2 viral load on risk of intubation and mortality among hospitalized patients with coronavirus disease 2019;Magleby;Clin Infect Dis,2021
4. COVID-19 mortality and vaccine coverage – Hong Kong special administrative region, China;Smith;China CDC Wkly 2022,2022
5. Preliminary Study of the Protectiveness of Vaccination Against the COVID-19 in the Outbreak of VOC Omicron BA.2 - Jilin City, Jilin Province, China;Fan;China CDC Wkly,2022